Laddar...
Chemotherapy and target therapy for hepatocellular carcinoma: New advances and challenges
Primary liver cancer is one of the commonest causes of death. Hepatocellular carcinoma (HCC) accounts for 90% of primary liver cancers. For patients with unresectable or metastatic HCC, conventional chemotherapy is of limited or no benefit. Sorafenib is the only systemic treatment to demonstrate a s...
Sparad:
| I publikationen: | World J Hepatol |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
Baishideng Publishing Group Inc
2015
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4404384/ https://ncbi.nlm.nih.gov/pubmed/25914779 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4254/wjh.v7.i5.787 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|